OpGen

OPGN78

High Growth

$2.10arrow_drop_down6.25%-$0.14

High Growth

Penny Stock

OPGN78

$2.10

arrow_drop_down6.25%-$0.14

High Growth

Penny Stock

Performance History

Key Stats
Open	$2.06
Prev. Close	$2.08
EPS	-40.32
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$18.71M
PE Ratio	-

	LOW	HIGH
Day Range	2.06	2.25
52 Week Range	1.75	38.40

Ratios







EPS	-40.32

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About OpGen (OPGN)

OpGen Inc (OPGN) is a biotechnology company that specializes in developing precision medicine solutions for infectious diseases. The company's innovative platform combines genomics, informatics, and phenotyping technologies to provide rapid and accurate diagnostics. With a focus on antibiotic resistance and hospital-acquired infections, OpGen is committed to improving patient outcomes and reducing healthcare costs. OpGen's stock price history has shown significant volatility, reflecting the uncertainties and risks inherent in the biotech industry. Investors should carefully consider their risk tolerance before investing in OPGN.

As of the latest quote, OpGen Inc is trading at $2.36 per share. The stock has recently experienced some positive news, such as collaborations with leading healthcare institutions and the launch of new products. These developments have generated interest among investors and may contribute to the company's future growth. However, it is important to note that the biotechnology sector is highly competitive and subject to regulatory challenges. Investors should conduct their own analysis and consider the long-term prospects of OpGen Inc.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Dr. Oliver Schacht Ph.D.
Headquarters: Rockville
Employees: 85
Exchange: NASDAQ

Keep an eye on OpGen

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is the market capitalization of OpGen (OPGN)?

OpGen (OPGN) has a market capitalization of $18.72M. The average daily trading volume is 2.5K, indicating the stock's liquidity and investor engagement.

help

What is OpGen 's (OPGN) price per share?

The current price per share for OpGen (OPGN) is $2.1. The stock has seen a price change of -$0.14 recently, indicating a -6.25% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for OpGen (OPGN)?

For OpGen (OPGN), the 52-week high is $38.4, which is 1.73K% from the current price. The 52-week low is $1.75, the current price is 20% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is OpGen (OPGN) a growth stock?

OpGen (OPGN) has shown an average price growth of 0.41% over the past three years. It has received a score of -1 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying OpGen as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is OpGen (OPGN) stock price performance year to date (YTD)?

As of the latest data, OpGen (OPGN) has a year-to-date price change of -50.84%. Over the past month, the stock has experienced a price change of -7.89%. Over the last three months, the change has been -14.98%. Over the past six months, the figure is -56.34%. Looking at a longer horizon, the five-year price change stands at -99.85%.

help

Is OpGen (OPGN) a profitable company?

OpGen (OPGN) has a net income of -$32.67M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -5.53K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $3.42M, with a revenue growth rate of 31.11%, providing insight into the company's sales performance and growth. Operating income is noted at -$30.75M. Furthermore, the EBITDA is -$8.07M.